This randomized controlled trial aims to evaluate the efficacy of biofeedback-assisted pelvic floor muscle training on radiation-induced sexual dysfunction in cervical cancer survivors following pelvic radiotherapy. Participants will be randomly assigned to receive either biofeedback-assisted pelvic floor rehabilitation or supervised conventional pelvic floor muscle training without biofeedback for 8 weeks.
Female participants aged 30-60 years.
Histologically confirmed diagnosis of cervical cancer (any stage at diagnosis) and completion of primary treatment.
Completion of pelvic radiotherapy (external beam radiotherapy and/or brachytherapy) ≥3 months prior to enrollment.
Presence of radiation-induced sexual dysfunction, defined as a Female Sexual Function Index (FSFI) score ≤26.55.
Evidence of recurrent, persistent, or metastatic cervical cancer.
Participation in pelvic floor muscle training or biofeedback-based rehabilitation within the previous 6 months.
Presence of severe pelvic organ prolapse (stage III-IV).
Active pelvic infection, pelvic inflammatory disease, or untreated vaginal infection.